Vol 3 (March 2018): AME Medical Journal

Comparison of pathological and oncologic outcomes in “favorable risk” GS 3+4 and low risk GS6 prostate cancer: considerations for active surveillance

My internship in AME: an unforgettable journal in my life

Portal vein thrombosis as a potential burden for liver transplant candidates in next future

Changing epidemiology in spontaneous bacterial peritonitis and challenging balance between new strategies in empirical antibiotics and emergence of resistant bacteria

The value of digital rectal examination in clinical practice

Hepatic inflammatory pseudotumor in a cirrhotic patient

Management of sciatica: a shared-decision

Cardiovascular disease and bone loss—new research in identifying common disease pathophysiologies and predictors

Targeting the glucocorticoid receptor for a combinatory treatment strategy for castration resistant prostate cancer?

Hepatitis C and liver transplantation in direct acting antiviral era

In search of real dynamical behavior of neural circuits

Increased risk of hepatocellular carcinoma after hepatitis C direct-acting antiviral drugs: the threat that never was

Non-alcoholic fatty liver disease and risk of developing chronic kidney disease: a new piece of a recent puzzle from a large Asian study

Hepatitis B and liver transplantation

Risk factors for adenocarcinoma and squamous cell carcinoma of the esophagus and lung

Role of Wnt inhibitor Apcdd1 in retinal angiogenesis and barrier formation

Management of malignant colorectal polyps—how to decide if polypectomy is enough?

Advances in the treatment of esophageal varices: assessing covered tips versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in patients with portal vein thrombosis

Adjuvant radiotherapy and mortality in lymph node-positive prostate cancer

PubMed Commons closure: a step back in post-publication peer review